[1]
F. Repetto, L. Burzi, S. Ribero, P. . Quaglino, and P. . Dapavo, “Efficacy and Safety of Risankizumab in Hidradenitis Suppurativa: A Case Series”, Acta Derm Venereol, vol. 102, p. adv00780, Sep. 2022.